TreeWAS – Variant ID: rs7952106

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	1.000	0.000	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	1.000	0.000	0.000
T39.1 4-Aminophenol derivatives	1.000	0.000	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.997	0.003	0.000
T43.2 Other and unspecified antidepressants	0.989	0.011	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.982	0.018	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.963	0.037	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.962	0.038	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.938	0.062	0.000
T40.2 Other opioids	0.928	0.072	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.913	0.087	0.000
T39.0 Salicylates	0.867	0.133	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.866	0.134	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.851	0.149	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.825	0.175	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.812	0.188	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.810	0.190	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.802	0.198	0.000
T50.8 Diagnostic agents	0.778	0.222	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.778	0.222	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.778	0.222	0.000
T40.6 Other and unspecified narcotics	0.772	0.228	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.746	0.254	0.000
T40.4 Other synthetic narcotics	0.743	0.257	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.738	0.262	0.000
T40.3 Methadone	0.738	0.262	0.000
T42.4 Benzodiazepines	0.731	0.269	0.000
T50.4 Drugs affecting uric acid metabolism	0.726	0.274	0.000
T39.4 Antirheumatics, not elsewhere classified	0.717	0.283	0.000
T39.2 Pyrazolone derivatives	0.717	0.283	0.000
T43.9 Psychotropic drug, unspecified	0.714	0.285	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.714	0.285	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.714	0.285	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.713	0.287	0.000
T46.1 Calcium-channel blockers	0.710	0.290	0.000
T50.7 Analeptics and opioid receptor antagonists	0.704	0.295	0.000
T50.5 Appetite depressants	0.704	0.295	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.704	0.295	0.000
T50.1 Loop [high-ceiling] diuretics	0.704	0.295	0.000
T50.0 Mineralocorticoids and their antagonists	0.704	0.295	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.693	0.307	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.690	0.310	0.000
T40.8 Lysergide [LSD]	0.690	0.310	0.000
T40.7 Cannabis (derivatives)	0.690	0.310	0.000
T40.0 Opium	0.690	0.310	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.678	0.322	0.000
T43.6 Psychostimulants with abuse potential	0.672	0.328	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.666	0.334	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.662	0.338	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.659	0.341	0.000
T38.1 Thyroid hormones and substitutes	0.658	0.342	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.655	0.345	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.655	0.345	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.655	0.345	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.655	0.345	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.655	0.345	0.000
T44.0 Anticholinesterase agents	0.655	0.345	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.653	0.347	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.650	0.350	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.647	0.353	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.639	0.361	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.630	0.370	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.627	0.373	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.620	0.379	0.000
T36 Poisoning by systemic antibiotics	0.616	0.384	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.611	0.388	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.608	0.392	0.000
T40.5 Cocaine	0.606	0.394	0.000
T40.1 Heroin	0.604	0.396	0.000
T38.9 Other and unspecified hormone antagonists	0.592	0.408	0.000
T38.7 Androgens and anabolic congeners	0.592	0.408	0.000
T38.5 Other oestrogens and progestogens	0.592	0.408	0.000
T38.4 Oral contraceptives	0.592	0.408	0.000
T38.2 Antithyroid drugs	0.592	0.408	0.000
T38.0 Glucocorticoids and synthetic analogues	0.587	0.413	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.582	0.418	0.000
T37.5 Antiviral drugs	0.582	0.418	0.000
T37.4 Anthelminthics	0.582	0.418	0.000
T37.3 Other antiprotozoal drugs	0.582	0.418	0.000
T37.1 Antimycobacterial drugs	0.582	0.418	0.000
T37.0 Sulphonamides	0.582	0.418	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.575	0.425	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.575	0.425	0.000
T46.7 Peripheral vasodilators	0.575	0.425	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.575	0.425	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.571	0.429	0.000
T42.1 Iminostilbenes	0.566	0.434	0.000
T42.3 Barbiturates	0.559	0.441	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.558	0.442	0.000
T42.2 Succinimides and oxazolidinediones	0.558	0.442	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.554	0.446	0.000
T41.2 Other and unspecified general anaesthetics	0.551	0.449	0.000
T47.4 Other laxatives	0.537	0.462	0.000
T41.5 Therapeutic gases	0.529	0.470	0.000
T41.4 Anaesthetic, unspecified	0.529	0.470	0.000
T41.3 Local anaesthetics	0.529	0.470	0.000
T41.1 Intravenous anaesthetics	0.529	0.470	0.000
T41.0 Inhaled anaesthetics	0.529	0.470	0.000
T47.2 Stimulant laxatives	0.519	0.481	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.513	0.487	0.000
T49.9 Topical agent, unspecified	0.511	0.489	0.000
T49.8 Other topical agents	0.511	0.489	0.000
T49.7 Dental drugs, topically applied	0.511	0.489	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.511	0.489	0.000
T49.5 Ophthalmological drugs and preparations	0.511	0.489	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.511	0.489	0.000
T49.3 Emollients, demulcents and protectants	0.511	0.489	0.000
T49.2 Local astringents and local detergents	0.511	0.489	0.000
T49.1 Antipruritics	0.511	0.489	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.507	0.493	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.497	0.503	0.000
T48.4 Expectorants	0.497	0.503	0.000
T48.3 Antitussives	0.497	0.503	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.497	0.503	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.497	0.503	0.000
T48.0 Oxytocic drugs	0.497	0.503	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.492	0.508	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.486	0.513	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.486	0.513	0.000
T47.7 Emetics	0.486	0.513	0.000
T47.5 Digestants	0.486	0.513	0.000
T47.3 Saline and osmotic laxatives	0.486	0.513	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.480	0.520	0.000
T48.5 Anti-common-cold drugs	0.477	0.522	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.475	0.525	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.461	0.539	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.457	0.542	0.000
T47.0 Histamine H(2)-receptor antagonists	0.455	0.545	0.000
T36.8 Other systemic antibiotics	0.455	0.545	0.000
T42.0 Hydantoin derivatives	0.446	0.554	0.000
T36.9 Systemic antibiotic, unspecified	0.442	0.558	0.000
T36.7 Antifungal antibiotics, systemically used	0.442	0.558	0.000
T36.6 Rifamycins	0.442	0.558	0.000
T36.5 Aminoglycosides	0.442	0.558	0.000
T36.2 Chloramphenicol group	0.442	0.558	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.442	0.558	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.431	0.569	0.000
T36.4 Tetracyclines	0.425	0.575	0.000
T36.3 Macrolides	0.418	0.581	0.000
T47.6 Antidiarrhoeal drugs	0.392	0.608	0.000
T36.0 Penicillins	0.378	0.622	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.360	0.640	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.331	0.668	0.001
T45.4 Iron and its compounds	0.309	0.691	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.309	0.691	0.000
T45.8 Other primarily systemic and haematological agents	0.309	0.691	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.309	0.691	0.000
T45.6 Fibrinolysis-affecting drugs	0.309	0.691	0.000
T45.3 Enzymes, not elsewhere classified	0.309	0.691	0.000
T45.2 Vitamins, not elsewhere classified	0.293	0.706	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.279	0.721	0.000
T45.5 Anticoagulants	0.273	0.727	0.000
T45.0 Antiallergic and antiemetic drugs	0.207	0.793	0.000
M50.1 Cervical disk disorder with radiculopathy	0.046	0.954	0.000
M50 Cervical disk disorders	0.037	0.963	0.000
M51 Other intervertebral disk disorders	0.031	0.969	0.000
M51.0 Lumbar and other intervertebral disk disorders with myelopathy	0.030	0.970	0.000
M50.9 Cervical disk disorder, unspecified	0.030	0.970	0.000
M50-M54 Other dorsopathies	0.030	0.970	0.000
M51.2 Other specified intervertebral disk displacement	0.029	0.971	0.000
M50.3 Other cervical disk degeneration	0.029	0.971	0.000
M50.8 Other cervical disk disorders	0.025	0.975	0.000
M50.0 Cervical disk disorder with myelopathy	0.024	0.976	0.000
M50.2 Other cervical disk displacement	0.024	0.976	0.000
M51.8 Other specified intervertebral disk disorders	0.024	0.976	0.000
M51.3 Other specified intervertebral disk degeneration	0.023	0.977	0.000
M51.1 Lumbar and other intervertebral disk disorders with radiculopathy	0.022	0.978	0.000
M54 Dorsalgia	0.022	0.978	0.000
M54.4 Lumbago with sciatica	0.021	0.979	0.000
M54.1 Radiculopathy	0.021	0.979	0.000
M51.9 Intervertebral disk disorder, unspecified	0.021	0.979	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.021	0.979	0.000
M51.4 Schmorl's nodes	0.020	0.980	0.000
F10.1 Harmful use	0.020	0.980	0.000
H26.4 After-cataract	0.020	0.980	0.000
F10.2 Dependence syndrome	0.018	0.982	0.000
M54.19 Radiculopathy (Site unspecified)	0.018	0.982	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.018	0.982	0.000
M54.17 Radiculopathy (Lumbosacral region)	0.018	0.982	0.000
M51.37 Other intervertebral disc degeneration, lumbosacral region	0.017	0.982	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.017	0.983	0.000
M54.10 Radiculopathy (Multiple sites in spine)	0.017	0.983	0.000
M54.14 Radiculopathy (Thoracic region)	0.016	0.984	0.000
M51.19 Lumbar and other intervertebral disc disorders with radiculopathy; site unspecified	0.016	0.984	0.000
M51.16 Intervertebral disc disorders w radiculopathy, lumbar region	0.016	0.984	0.000
M54.2 Cervicalgia	0.016	0.984	0.000
M54.9 Dorsalgia, unspecified	0.016	0.984	0.000
M54.16 Radiculopathy (Lumbar region)	0.016	0.984	0.000
M54.0 Panniculitis affecting regions of neck and back	0.016	0.984	0.000
Z33 Pregnant state, incidental	0.000	0.984	0.016
M54.12 Radiculopathy (Cervical region)	0.016	0.984	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.015	0.984	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.016	0.984	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.015	0.984	0.000
M54.44 Lumbago with sciatica-Thoracic	0.015	0.984	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.015	0.984	0.000
M54.42 Lumbago with sciatica-Cervical	0.015	0.984	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.015	0.984	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.015	0.984	0.000
M54.29 Cervicalgia-Site unspe	0.016	0.984	0.000
M54.18 Radiculopathy (Sacral and sacrococcygeal region)	0.015	0.984	0.000
M54.15 Radiculopathy (Thoracolumbar region)	0.015	0.985	0.000
M54.13 Radiculopathy (Cervicothoracic region)	0.015	0.985	0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)	0.015	0.985	0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.000	0.985	0.015
M54.90 Dorsalgia, unspecified (Multiple sites in spine)	0.015	0.985	0.000
Z32 Pregnancy examination and test	0.000	0.985	0.015
Z35 Supervision of high-risk pregnancy	0.000	0.985	0.015
Z32.1 Pregnancy confirmed	0.000	0.985	0.015
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.985	0.014
Z36 Antenatal screening	0.000	0.986	0.014
F10.6 Amnesic syndrome	0.014	0.986	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.986	0.014
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.986	0.014
M54.94 Dorsalgia, unspecified (Thoracic region)	0.013	0.987	0.000
F10.9 Unspecified mental and behavioural disorder	0.013	0.987	0.000
M53 Other dorsopathies, not elsewhere classified	0.013	0.987	0.000
M54.6 Pain in thoracic spine	0.013	0.987	0.000
F10.8 Other mental and behavioural disorders	0.013	0.987	0.000
Z38 Liveborn infants according to place of birth	0.000	0.987	0.013
Z35.8 Supervision of other high-risk pregnancies	0.000	0.987	0.013
Z35.0 Supervision of pregnancy with history of infertility	0.000	0.987	0.013
M54.93 Dorsalgia, unspecified (Cervicothoracic region)	0.012	0.987	0.000
M54.8 Other dorsalgia	0.012	0.988	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.012	0.988	0.000
T51.0 Ethanol	0.012	0.988	0.000
F10.3 Withdrawal state	0.012	0.988	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.000	0.988	0.012
F10.0 Acute intoxication	0.012	0.988	0.000
M54.97 Dorsalgia, unspecified (Lumbosacral region)	0.012	0.988	0.000
M54.27 Cervicalgia-Lumbosacral	0.012	0.988	0.000
M54.26 Cervicalgia-Lumbar	0.012	0.988	0.000
M54.25 Cervicalgia-Thoracolumbar	0.012	0.988	0.000
M54.24 Cervicalgia-Thoracic	0.012	0.988	0.000
M54.20 Cervicalgia-Mult site	0.012	0.988	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.012	0.988	0.000
F10.4 Withdrawal state with delirium	0.012	0.988	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.000	0.988	0.012
M54.91 Dorsalgia, unspecified (Occipito-atlanto-axial region)	0.012	0.988	0.000
M54.09 Panniculitis affecting regions of neck and back (Site unspecified)	0.011	0.988	0.000
M54.08 Panniculitis affecting regions of neck and back (Sacral and sacrococcygeal region)	0.011	0.988	0.000
M54.07 Panniculitis affecting regions of neck and back (Lumbosacral region)	0.011	0.988	0.000
M54.06 Panniculitis affecting regions of neck and back (Lumbar region)	0.011	0.988	0.000
M54.05 Panniculitis affecting regions of neck and back (Thoracolumbar region)	0.011	0.988	0.000
M54.04 Panniculitis affecting regions of neck and back (Thoracic region)	0.011	0.988	0.000
M54.03 Panniculitis affecting regions of neck and back (Cervicothoracic region)	0.011	0.988	0.000
M54.02 Panniculitis affecting regions of neck and back (Cervical region)	0.011	0.988	0.000
M54.01 Panniculitis affecting regions of neck and back (Occipito-atlanto-axial region)	0.011	0.988	0.000
M54.00 Panniculitis affecting regions of neck and back (Multiple sites in spine)	0.011	0.988	0.000
Z39 Postpartum care and examination	0.000	0.988	0.012
Z38.0 Singleton, born in hospital	0.000	0.988	0.012
Z34 Supervision of normal pregnancy	0.000	0.989	0.011
Z32.9 Pregnancy confirmed (erroneous code. See Z321)	0.000	0.989	0.011
Z35.7 Supervision of high-risk pregnancy due to social problems	0.000	0.989	0.011
Z35.6 Supervision of very young primigravida	0.000	0.989	0.011
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.000	0.989	0.011
M54.96 Dorsalgia, unspecified (Lumbar region)	0.011	0.989	0.000
M54.95 Dorsalgia, unspecified (Thoracolumbar region)	0.011	0.989	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.011	0.989	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.000	0.989	0.011
M54.98 Dorsalgia, unspecified (Sacral and sacrococcygeal region)	0.011	0.989	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.011	0.989	0.000
M54.92 Dorsalgia, unspecified (Cervical region)	0.010	0.990	0.000
F10.7 Residual and late-onset psychotic disorder	0.010	0.990	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.990	0.010
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.990	0.010
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.990	0.010
Z37 Outcome of delivery	0.000	0.990	0.010
Z35.5 Supervision of elderly primigravida	0.000	0.990	0.010
M53.1 Cervicobrachial syndrome	0.009	0.990	0.000
M53.0 Cervicocranial syndrome	0.009	0.990	0.000
M54.69 Pain in thoracic spine-Site unspe	0.009	0.990	0.000
M54.68 Pain in thoracic spine-Sacral/sacrococ	0.009	0.990	0.000
M54.67 Pain in thoracic spine-Lumbosacral	0.009	0.990	0.000
M54.66 Pain in thoracic spine-Lumbar	0.009	0.990	0.000
M54.65 Pain in thoracic spine (Thoracolumbar region)	0.009	0.990	0.000
M54.62 Pain in thoracic spine-Cervical	0.009	0.990	0.000
M54.61 Pain in thoracic spine-Occipit-atl-axl	0.009	0.990	0.000
M54.60 Pain in thoracic spine (Multiple sites in spine)	0.009	0.990	0.000
M54.87 Other dorsalgia (Lumbosacral region)	0.009	0.990	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.010	0.990	0.000
Z38.8 Other multiple, unspecified as to place of birth	0.000	0.990	0.009
Z38.7 Other multiple, born outside hospital	0.000	0.990	0.009
Z38.6 Other multiple, born in hospital	0.000	0.990	0.009
Z38.5 Twin, unspecified as to place of birth	0.000	0.990	0.009
Z38.4 Twin, born outside hospital	0.000	0.990	0.009
Z38.3 Twin, born in hospital	0.000	0.990	0.009
Z38.2 Singleton, unspecified as to place of birth	0.000	0.990	0.009
Z38.1 Singleton, born outside hospital	0.000	0.990	0.009
Z36.9 Antenatal screening, unspecified	0.000	0.990	0.010
F10.5 Psychotic disorder	0.009	0.991	0.000
M54.80 Other dorsalgia (Multiple sites in spine)	0.009	0.991	0.000
M54.84 Other dorsalgia (Thoracic region)	0.009	0.991	0.000
M54.88 Other dorsalgia (Sacral and sacrococcygeal region)	0.009	0.991	0.000
M54.85 Other dorsalgia (Thoracolumbar region)	0.009	0.991	0.000
M54.83 Other dorsalgia (Cervicothoracic region)	0.009	0.991	0.000
M54.82 Other dorsalgia (Cervical region)	0.009	0.991	0.000
M54.81 Other dorsalgia (Occipito-atlanto-axial region)	0.009	0.991	0.000
Z39.0 Care and examination immediately after delivery	0.000	0.991	0.009
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.991	0.009
M53.8 Other specified dorsopathies	0.009	0.991	0.000
Z34.0 Supervision of normal first pregnancy	0.000	0.991	0.009
M54.63 Pain in thoracic spine (Cervicothoracic region)	0.009	0.991	0.000
F19.1 Harmful use	0.009	0.991	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.009	0.991	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.009	0.991	0.000
M53.2 Spinal instabilities	0.008	0.991	0.000
M53.9 Dorsopathy, unspecified	0.008	0.991	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.991	0.008
M43.16 Spondylolisthesis (Lumbar region)	0.008	0.992	0.000
Z39.2 Routine postpartum follow-up	0.000	0.992	0.008
Z39.1 Care and examination of lactating mother	0.000	0.992	0.008
M54.64 Pain in thoracic spine (Thoracic region)	0.008	0.992	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.008	0.992	0.000
M54.86 Other dorsalgia (Lumbar region)	0.008	0.992	0.000
Z37.2 Twins, both liveborn	0.000	0.992	0.008
Z37.5 Other multiple births, all liveborn	0.000	0.992	0.008
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.008	0.992	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.008	0.992	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.008	0.992	0.000
F19.2 Dependence syndrome	0.008	0.992	0.000
Z37.1 Single stillbirth	0.000	0.992	0.008
M53.3 Sacrococcygeal disorders, not elsewhere classified	0.007	0.992	0.000
Z37.3 Twins, one liveborn and one stillborn	0.000	0.992	0.008
F14.1 Harmful use	0.008	0.992	0.000
Z37.9 Outcome of delivery unspecified	0.000	0.992	0.007
Z37.7 Other multiple births, all stillborn	0.000	0.992	0.007
Z37.6 Other multiple births, some liveborn	0.000	0.992	0.007
Z37.4 Twins, both stillborn	0.000	0.992	0.007
J02.9 Acute pharyngitis, unspecified	0.007	0.993	0.000
F19.3 Withdrawal state	0.007	0.993	0.000
Z36.8 Other antenatal screening	0.000	0.993	0.007
M53.09 Cervicocranial syndrome-Site unspe	0.007	0.993	0.000
M53.08 Cervicocranial syndrome-Sacral/sacrococ	0.007	0.993	0.000
M53.07 Cervicocranial syndrome-Lumbosacral	0.007	0.993	0.000
M53.06 Cervicocranial syndrome-Lumbar	0.007	0.993	0.000
M53.05 Cervicocranial syndrome-Thoracolumbar	0.007	0.993	0.000
M53.04 Cervicocranial syndrome-Thoracic	0.007	0.993	0.000
M53.03 Cervicocranial syndrome (Cervicothoracic region)	0.007	0.993	0.000
M53.02 Cervicocranial syndrome (Cervical region)	0.007	0.993	0.000
M53.01 Cervicocranial syndrome (Occipito-atlanto-axial region)	0.007	0.993	0.000
M53.00 Cervicocranial syndrome (Multiple sites in spine)	0.007	0.993	0.000
M53.19 Cervicobrachial syndrome-Site unspe	0.007	0.993	0.000
M53.18 Cervicobrachial syndrome-Sacral/sacrococ	0.007	0.993	0.000
M53.17 Cervicobrachial syndrome-Lumbosacral	0.007	0.993	0.000
M53.16 Cervicobrachial syndrome-Lumbar	0.007	0.993	0.000
M53.15 Cervicobrachial syndrome-Thoracolumbar	0.007	0.993	0.000
M53.14 Cervicobrachial syndrome-Thoracic	0.007	0.993	0.000
M53.13 Cervicobrachial syndrome (Cervicothoracic region)	0.007	0.993	0.000
M53.12 Cervicobrachial syndrome (Cervical region)	0.007	0.993	0.000
M53.11 Cervicobrachial syndrome (Occipito-atlanto-axial region)	0.007	0.993	0.000
M53.10 Cervicobrachial syndrome (Multiple sites in spine)	0.007	0.993	0.000
F19.9 Unspecified mental and behavioural disorder	0.007	0.993	0.000
F19.8 Other mental and behavioural disorders	0.007	0.993	0.000
F19.7 Residual and late-onset psychotic disorder	0.007	0.993	0.000
F19.6 Amnesic syndrome	0.007	0.993	0.000
F19.5 Psychotic disorder	0.007	0.993	0.000
F19.4 Withdrawal state with delirium	0.007	0.993	0.000
F19.0 Acute intoxication	0.007	0.993	0.000
F11 Mental and behavioural disorders due to use of opioids	0.007	0.993	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.000	0.993	0.007
F12.1 Harmful use	0.007	0.993	0.000
F12.2 Dependence syndrome	0.007	0.993	0.000
M53.86 Other specified dorsopathies (Lumbar region)	0.007	0.993	0.000
I33.0 Acute and subacute infective endocarditis	0.007	0.993	0.000
T51 Toxic effect of alcohol	0.007	0.993	0.000
C77.3 Axillary and upper limb lymph nodes	0.007	0.993	0.000
C91.1 Chronic lymphocytic leukaemia	0.007	0.993	0.000
M53.89 Other specified dorsopathies (Site unspecified)	0.006	0.993	0.000
M53.88 Other specified dorsopathies (Sacral and sacrococcygeal region)	0.006	0.993	0.000
M53.87 Other specified dorsopathies (Lumbosacral region)	0.006	0.993	0.000
M53.85 Other specified dorsopathies (Thoracolumbar region)	0.006	0.993	0.000
M53.84 Other specified dorsopathies (Thoracic region)	0.006	0.993	0.000
M53.83 Other specified dorsopathies (Cervicothoracic region)	0.006	0.993	0.000
M53.81 Other specified dorsopathies (Occipito-atlanto-axial region)	0.006	0.993	0.000
M53.80 Other specified dorsopathies (Multiple sites in spine)	0.006	0.993	0.000
F14.9 Unspecified mental and behavioural disorder	0.006	0.993	0.000
F14.8 Other mental and behavioural disorders	0.006	0.993	0.000
F14.7 Residual and late-onset psychotic disorder	0.006	0.993	0.000
F14.6 Amnesic syndrome	0.006	0.993	0.000
F14.5 Psychotic disorder	0.006	0.993	0.000
F14.4 Withdrawal state with delirium	0.006	0.993	0.000
F14.3 Withdrawal state	0.006	0.993	0.000
F14.0 Acute intoxication	0.006	0.993	0.000
H26 Other cataract	0.007	0.993	0.000
M53.26 Spinal instabilities (Lumbar region)	0.006	0.993	0.000
F12.9 Unspecified mental and behavioural disorder	0.006	0.993	0.000
F12.8 Other mental and behavioural disorders	0.006	0.993	0.000
F12.7 Residual and late-onset psychotic disorder	0.006	0.993	0.000
F12.6 Amnesic syndrome	0.006	0.993	0.000
F12.5 Psychotic disorder	0.006	0.993	0.000
F12.4 Withdrawal state with delirium	0.006	0.993	0.000
F12.3 Withdrawal state	0.006	0.993	0.000
M54.89 Other dorsalgia (Site unspecified)	0.006	0.993	0.000
M53.29 Spinal instabilities (Site unspecified)	0.006	0.994	0.000
M53.28 Spinal instabilities (Sacral and sacrococcygeal region)	0.006	0.994	0.000
M53.25 Spinal instabilities (Thoracolumbar region)	0.006	0.994	0.000
M53.24 Spinal instabilities (Thoracic region)	0.006	0.994	0.000
M53.23 Spinal instabilities (Cervicothoracic region)	0.006	0.994	0.000
M53.21 Spinal instabilities (Occipito-atlanto-axial region)	0.006	0.994	0.000
M53.20 Spinal instabilities (Multiple sites in spine)	0.006	0.994	0.000
F12.0 Acute intoxication	0.006	0.994	0.000
M53.98 Dorsopathy, unspecified (Sacral and sacrococcygeal region)	0.006	0.994	0.000
M53.97 Dorsopathy, unspecified (Lumbosacral region)	0.006	0.994	0.000
M53.95 Dorsopathy, unspecified (Thoracolumbar region)	0.006	0.994	0.000
M53.94 Dorsopathy, unspecified (Thoracic region)	0.006	0.994	0.000
M53.93 Dorsopathy, unspecified (Cervicothoracic region)	0.006	0.994	0.000
M53.92 Dorsopathy, unspecified (Cervical region)	0.006	0.994	0.000
M53.91 Dorsopathy, unspecified (Occipito-atlanto-axial region)	0.006	0.994	0.000
M53.90 Dorsopathy, unspecified (Multiple sites in spine)	0.006	0.994	0.000
M53.22 Spinal instabilities (Cervical region)	0.006	0.994	0.000
M53.99 Dorsopathy, unspecified (Site unspecified)	0.006	0.994	0.000
G55.1 Nerve root and plexus compressions in intervertebral disk disorders	0.006	0.994	0.000
F14.2 Dependence syndrome	0.006	0.994	0.000
F15.1 Harmful use	0.006	0.994	0.000
H01.0 Blepharitis	0.006	0.994	0.000
F11.2 Dependence syndrome	0.006	0.994	0.000
F13.2 Dependence syndrome	0.006	0.994	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.994	0.006
F15.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F15.8 Other mental and behavioural disorders	0.006	0.994	0.000
F15.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F15.6 Amnesic syndrome	0.006	0.994	0.000
F15.5 Psychotic disorder	0.006	0.994	0.000
F15.4 Withdrawal state with delirium	0.006	0.994	0.000
F15.3 Withdrawal state	0.006	0.994	0.000
F15.2 Dependence syndrome	0.006	0.994	0.000
F15.0 Acute intoxication	0.006	0.994	0.000
H26.1 Traumatic cataract	0.006	0.994	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.006	0.994	0.000
F13.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F13.8 Other mental and behavioural disorders	0.006	0.994	0.000
F13.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F13.6 Amnesic syndrome	0.006	0.994	0.000
F13.5 Psychotic disorder	0.006	0.994	0.000
F13.4 Withdrawal state with delirium	0.006	0.994	0.000
F13.1 Harmful use	0.006	0.994	0.000
F13.0 Acute intoxication	0.006	0.994	0.000
F16.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F16.8 Other mental and behavioural disorders	0.006	0.994	0.000
F16.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F16.6 Amnesic syndrome	0.006	0.994	0.000
F16.5 Psychotic disorder	0.006	0.994	0.000
F16.4 Withdrawal state with delirium	0.006	0.994	0.000
F16.3 Withdrawal state	0.006	0.994	0.000
F16.2 Dependence syndrome	0.006	0.994	0.000
F16.1 Harmful use	0.006	0.994	0.000
F16.0 Acute intoxication	0.006	0.994	0.000
F18.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F18.8 Other mental and behavioural disorders	0.006	0.994	0.000
F18.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F18.6 Amnesic syndrome	0.006	0.994	0.000
F18.5 Psychotic disorder	0.006	0.994	0.000
F18.4 Withdrawal state with delirium	0.006	0.994	0.000
F18.3 Withdrawal state	0.006	0.994	0.000
F18.2 Dependence syndrome	0.006	0.994	0.000
F18.1 Harmful use	0.006	0.994	0.000
F18.0 Acute intoxication	0.006	0.994	0.000
M53.37 Sacrococcygeal disorders, not elsewhere classified-Lumbosac	0.005	0.994	0.000
M53.36 Sacrococcygeal disorders, not elsewhere classified-Lumbar	0.005	0.994	0.000
M53.35 Sacrococcygeal disorders, not elsewhere classified-Thoracol	0.005	0.994	0.000
M53.34 Sacrococcygeal disorders, not elsewhere classified-Thoracic	0.005	0.994	0.000
M53.33 Sacrococcygeal disorders, not elsewhere classified-Cervicot	0.005	0.994	0.000
M53.32 Sacrococcygeal disorders, not elsewhere classified-Cervical	0.005	0.994	0.000
M53.31 Sacrococcygeal disorders, not elsewhere classified-Occipit-	0.005	0.994	0.000
M53.30 Sacrococcygeal disorders, not elsewhere classified-Mult sit	0.005	0.994	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.006	0.994	0.000
F13.3 Withdrawal state	0.006	0.994	0.000
Z31 Procreative management	0.000	0.994	0.006
M53.82 Other specified dorsopathies (Cervical region)	0.005	0.994	0.000
M53.39 Sacrococcygeal disorders, not elsewhere classified-Site uns	0.005	0.994	0.000
F11.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F11.8 Other mental and behavioural disorders	0.005	0.995	0.000
F11.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F11.6 Amnesic syndrome	0.005	0.995	0.000
F11.5 Psychotic disorder	0.005	0.995	0.000
F11.4 Withdrawal state with delirium	0.005	0.995	0.000
M53.96 Dorsopathy, unspecified (Lumbar region)	0.005	0.995	0.000
H73.8 Other specified disorders of tympanic membrane	0.005	0.995	0.000
M53.27 Spinal instabilities (Lumbosacral region)	0.005	0.995	0.001
H26.0 Infantile, juvenile and presenile cataract	0.005	0.995	0.000
F11.3 Withdrawal state	0.005	0.995	0.000
J02 Acute pharyngitis	0.005	0.995	0.000
T51.8 Other alcohols	0.005	0.995	0.000
T51.3 Fusel oil	0.005	0.995	0.000
T51.2 2-Propanol	0.005	0.995	0.000
T51.1 Methanol	0.005	0.995	0.000
F11.1 Harmful use	0.005	0.995	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.005	0.995	0.000
H26.3 Drug-induced cataract	0.005	0.995	0.000
H26.8 Other specified cataract	0.005	0.995	0.000
J02.8 Acute pharyngitis due to other specified organisms	0.005	0.995	0.000
M54.22 Cervicalgia (Cervical region)	0.005	0.995	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.000	0.995	0.005
T51.9 Alcohol, unspecified	0.005	0.995	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.995	0.005
Z31.8 Other procreative management	0.000	0.995	0.004
M41.9 Scoliosis, unspecified	0.005	0.995	0.000
M43.1 Spondylolisthesis	0.005	0.995	0.000
F11.0 Acute intoxication	0.004	0.996	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations